Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Antithrombin Iii Deficiency

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Antithrombin Iii Deficiency:

Pubmed Logo
A novel approach for resection of a vaginal septum.
BACKGROUND: The resection of a vaginal septum using the Harmonic Scalpel...
23rd October, 2009
Department of Obstetrics and Gynecology, University of Utah Hospitals and J Pediatr Adolesc Gynecol. 2009 Aug;22(4):e69-70.
DOI Direct Link
[Heparin resistance and antithrombin deficiency]
The phenomenon of heparin resistance (HR) is characterized by high doses...
6th October, 2009
KfH-Nierenzentrum Neuwied, Med Klin (Munich). 2009 Jun 15;104(6):441-9. Epub 2009 Jun 16.
DOI Direct Link
Acute mesenteric venous thrombosis: improved outcome with early diagnosis and prompt anticoagulation therapy.
AIM: To analyze the clinical spectrum of acute mesenteric venous...
30th September, 2009
Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan. Int J Surg. 2009 Jun;7(3):210-3. Epub 2009 Mar 28.
DOI Direct Link
Thrombophilia of nephrotic syndrome in adults.
BACKGROUND: The resection of a vaginal septum using the Harmonic Scalpel...
29th September, 2009
Biomedical Research Centre, Guy's and St Thomas' Foundation Hospitals, Clin Adv Hematol Oncol. 2009 Jun;7(6):368-72.
The inefficacy of enoxaparin prophylaxis in a patient with congenital antithrombin deficiency.
Antithrombin (AT) functions as a potent natural anticoagulant and serine...
9th September, 2009
Clin Appl Thromb Hemost. 2009 Mar-Apr;15(2):241.
DOI Direct Link

View more research publications.

Press Releases About Antithrombin Iii Deficiency:

BioPortfolio Logo
United American Healthcare Corporation Announces Fiscal 2010 First Quarter Results 16th November, 2009 United American Healthcare Corporation
DETROIT, Nov. 16 /PRNewswire-FirstCall/ -- United American Healthcare Corporation (Nasdaq: UAHC) today announced financial results for the Company's fiscal first quarter ended Sept. 30, 2009.
Catalyst Receives Guidance from Nasdaq Regarding Minimum Bid Price Requirement 13th November, 2009 Catalyst Pharmaceutical Partners, Inc.
CORAL GABLES, Fla., Nov. 13 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (NasdaqCM: CPRX) announced today that it received a Nasdaq Staff Deficiency Letter dated November 13, 2009
AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 11th November, 2009 AETERNA ZENTARIS INC.
All amounts are in U.S. dollars QUEBEC CITY, Nov. 11 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on
Nielsen Announces Finalists for the First-Ever CLIO Healthcare Awards 21st October, 2009 The Nielsen Company
-- Company: Brown Parker & DeMarinis Advertising Innovative Media: Direct to Consumer -- Corporate Comms./Health Care Providers/Health Insurance/Managed Care Plans
Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C 19th October, 2009 Talecris Biotherapeutics
RESEARCH TRIANGLE PARK, N.C., Oct. 19 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics (Nasdaq: TLCR) today received approval from the U.S. Food and Drug Administration for PROLASTIN®-C (Alpha1

Antithrombin Iii Deficiency Clinical Trials:

Clinical Trials Logo
Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery

Antithrombin Iii Deficiency Patents:

USPTO Logo
US Patent No.Title
6455532 Pyrazinone thrombin inhibitors
6919457 3-(imidazolyl)-2-aminopropanoic acids
6949577 Pharmaceuticals
6958402 3-(imidazolyl)-2-alkoxypropanoic acids
6960352 Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Antithrombin Iii Deficiency scientists - we have details of around 115 individuals working on Antithrombin Iii Deficiency .


This page has been viewed 529 times
Recent Search Terms used to find this page: antithrombin 3 deficiency surgery | antithrombin iii deficiency | antithrombin 3 deficiency immune | Grifols Antithrombin III | antithrombin 111 deficiency | surgery antithrombin 3 deficiency | Heparin resistance and antithrombin deficiency | what is antithrombin 111 | antithrombin 111 deficiency | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Antithrombin Iii Deficiency across BioPortfolio, or for Antithrombin Iii Deficiency Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.